Purchase Order HT942524P0078
Award Date 6/21/24
Potential Completion Date 1/20/25
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Collins, CO 80521, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,298,431.22 firm fixed price contract awarded by the Defense Health Agency (DHA) to Solaris Vaccines, Inc., a small business located in Fort Collins, CO. The contract is for Phase II of the Small Business Innovation Research (SBIR) program and is for the development of a "VacciraRptor: High-Throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation." The contract has a performance period through November 1, 2027. This award is for a specific research and...
- This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
- The Defense Health Agency awarded a $3.93 million firm fixed-price definitive contract to Hexamer Therapeutics Inc. on September 29, 2023, for the development of a peptide-based, self-assembling molecular carrier scaffold vaccine platform designed for rapid deployment during infectious disease pandemics. The contract, which extends through March 31, 2027, will be performed at Hexamer's facility in Pullman, Washington. This award was issued under a Broad Agency Announcement solicitation from...
- This is a $2,574,853.28 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Technovax Inc., a Minority Owned, Self Certified Small Disadvantaged Business, for the "Next-Generation Adenovirus Vaccine" under the ARMY 15.1 SBIR (Small Business Innovation Research) program. The contract is set aside for Small Businesses and has a period of performance through March 31, 2023. The contract is associated with the National Interest Action Code for the Coronavirus...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Sanaria Inc., a veteran-owned biotechnology company, for the development of a "Delivery System for Cryopreserved Eukaryotic Cell Vaccines." The potential value of this definitive, firm fixed-price contract is $149,994.23. Sanaria Inc. has prior experience providing services to support malaria drug development and vaccine clinical trials for federal agencies...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Sanaria Inc., a biotechnology company focused on the development of malaria vaccines. The $149,931.25 firm-fixed-price purchase order is for the delivery of purified, vialed, and cryopreserved products, with a period of performance ending on February 29, 2016. Sanaria Inc. has previously received federal grants and contracts related to the research, development, and...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $149,999 firm-fixed-price purchase order contract to Cyanvac LLC, a minority-owned small business, for SBIR Phase I work. Cyanvac is developing viral vector vaccines, including intranasal vaccine candidates against respiratory viruses such as SARS-CoV-2, respiratory syncytial virus (RSV), and human metapneumovirus (HMPV). The company has previously received over $700,000 in prime federal grants...
- The U.S. Department of Defense Medical Supply Chain has awarded a $1,153.52 firm fixed-price purchase order to Sanofi Pasteur Inc. for influenza virus vaccine. The award, issued on October 2, 2025, with an ultimate completion date of October 7, 2025, represents a small-value delivery order with no set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, serves as the prime contractor and will fulfill this requirement...
- This definitive contract awarded by the Department of the Army Medical Command to Luna Innovations Incorporated is a Phase II Small Business Innovation Research project valued at $1.5 million. Under this firm fixed price award, Luna Innovations will conduct medical research and development efforts relating to a COVID-19 vaccine utilizing a layer-by-layer delivery of multiple antigens. The work will be performed in Roanoke, Virginia through September 2023. The solicitation sought proposals to...
- The U.S. Department of Defense Medical Supply Chain awarded a $486,741.33 firm fixed-price delivery order to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on December 12, 2025, for the procurement of influenza virus vaccine. The contract, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is a foreign-owned pharmaceutical manufacturer and established...